Found 46 articles for: "finasteride"
Hydroxychloroquine-Induced Nonthrombocytopenic Purpura: A Case Series
May 2024 | Volume 23 | Issue 5 | Case Reports | 7781 | Copyright © May 2024
Hydroxychloroquine (HCQ) is a disease-modifying anti-rheumatic medication for the treatment of various autoimmune conditions. A rare side effect of HCQ is thrombotic thrombocytopenic purpura (TTP). We...
Read MoreHighlighting the Link Between Lichen Planus Pigmentosus and Frontal Fibrosing Alopecia
March 2024 | Volume 23 | Issue 3 | Features | 196 | Copyright © March 2024
Survey of the Prices of Topical Compounded Medications for Alopecia in the Tri-State Area
March 2024 | Volume 23 | Issue 3 | Original Article | 168 | Copyright © March 2024
Background: Currently, there is only one topical medication approved by the U.S. Food and Drug Administration for alopecia, minoxidil 2.5% and 5%. With limited options, dermatolo...
Read MoreSurvey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia
March 2024 | Volume 23 | Issue 3 | Original Article | 136 | Copyright © March 2024
Background: Utilization of low-dose oral minoxidil has increased in recent years in association with several clinical studies that have shown its efficacy in treating androgeneti...
Read MoreOral Minoxidil Media Coverage: The Impact on Patient Perceptions and Practitioner Approaches to Androgenetic Alopecia
January 2024 | Volume 23 | Issue 1 | Editorials | 1364 | Copyright © January 2024
A Randomized Control Trial Comparing the Efficacy of Platelet-Rich Plasma and 5% Topical Minoxidil for the Treatment of Androgenetic Alopecia
September 2023 | Volume 22 | Issue 9 | Original Article | 905 | Copyright © September 2023
Androgenetic alopecia (AGA) is the most common cause of hair loss in men and has limited treatment options. Minoxidil is a common therapeutic option for AGA patients because of its availability. Plate...
Read MoreHormonal Treatments in Hidradenitis Suppurativa: A Systematic Review
August 2023 | Volume 22 | Issue 8 | Original Article | 785 | Copyright © August 2023
Background: Hidradenitis suppurativa (HS) is an inflammatory skin condition characterized by recurrent abscesses, nodules, and sinus tracts. Hormones are thought to play an impor...
Read MoreReal-World, Open-Label Study of the Efficacy and Safety of a Novel Serum in Androgenetic Alopecia
June 2023 | Volume 22 | Issue 6 | Original Article | 559 | Copyright © June 2023
Pattern-type hair loss is a highly prevalent condition affecting the majority of men and women at some point in their lifetime. Although genetics and androgens are instrumental in the pathogenesi...
Read MoreGender-Affirming Hormone Therapy Among Transgender and Gender Diverse Patients Receiving Laser Hair Removal Prior to Gender-Affirming Surgery
June 2023 | Volume 22 | Issue 6 | Editorials | 619 | Copyright © June 2023
Update on Hormonal Therapy in Hidradenitis Suppurativa
April 2023 | Volume 22 | Issue 4 | Original Article | 369 | Copyright © April 2023
Hidradenitis suppurativa (HS), a chronic inflammatory disorder of the apocrine-bearing skin, presents with deep seated inflamed nodules, abscesses, draining sinus tracts, and scarring with a prof...
Read MoreEvaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of Androgenetic Alopecia
November 2022 | Volume 21 | Issue 11 | Original Article | 1166 | Copyright © November 2022
Androgenetic alopecia (AGA) in men and women is the most common cause of hair loss. Affected individuals may experience psychological distress and social withdrawal. Current treatment options for AGA,...
Read MorePlatelet-Rich Plasma Monotherapies for Androgenetic Alopecia: A Network Meta-Analysis and Meta-Regression Study
September 2022 | Volume 21 | Issue 9 | Original Article | 943 | Copyright © September 2022
Introduction: Platelet-rich plasma (PRP) is a commonly used therapeutic option for androgenetic alopecia (AGA). Evidence syntheses for the impact of PRP on AGA has been handicapped by...
Read MoreA Long-Term Study of the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Perimenopausal, Menopausal, and Postmenopausal Women
July 2022 | Volume 21 | Issue 7 | Original Article | 783 | Copyright © July 2022
The prevalence of female hair loss and hair thinning increases with advancing age and is most common among post-menopausal women. Recent statistics show that by age 60, an estimated 80% of women exper...
Read MoreAdherence and Persistence to Acne Medications: A Population-Based Claims Database Analysis
July 2022 | Volume 21 | Issue 7 | Original Article | 758 | Copyright © July 2022
Background: The chronicity of acne and its treatment with topicals contribute to poor treatment adherence and persistence. How well newly diagnosed acne patients use their treatment i...
Read MoreMesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice
July 2022 | Volume 21 | Issue 7 | Original Article | 742 | Copyright © July 2022
Background: 5-alpha inhibitors are an effective treatment for androgenetic alopecia. Mesotherapy with dutasteride has been proposed as an effective method to improve hair loss and red...
Read MoreHormonal Therapies in the Management of Acne Vulgaris
June 2022 | Volume 21 | Issue 6 | Original Article | 618 | Copyright © June 2022
Acne vulgaris is a multifactorial chronic disorder of the pilosebaceous unit. Established treatments include topical retinoids, antibiotics in mild cases, and oral antibiotics and isotretinoin in mode...
Read MoreReversible Hair Loss in Lichen Planopilaris: Regrowth With Low-Dose Naltrexone and Platelet-Rich Plasma
June 2022 | Volume 21 | Issue 6 | Case Reports | 671 | Copyright © June 2022
Lichen planopilaris (LPP) is a cicatricial alopecia that presents with patchy or diffuse hair loss at the vertex or parietal scalp. The literature has limited evidence on treatments for this challengi...
Read MoreA Systematic Review: Application of Rice Products for Hair Growth
February 2022 | Volume 21 | Issue 2 | Original Article | 177 | Copyright © February 2022
Background: Rice bran extracts (RB) derived from Oryza sativa are part of cultural skin and hair care practices in Asia. Given the knowledge gap regarding clinical efficacy, ...
Read MoreImpact of Laboratory Work Up and Supplementation on Alopecia Patients: A Single-Center Retrospective Chart Review
July 2021 | Volume 20 | Issue 7 | Editorials | 807 | Copyright © July 2021
Evaluation of alopecia often includes laboratory testing for ferritin, thyroid stimulating hormone, vitamin D, and zinc as previous studies have found associations between non-scarring alopecia and vi...
Read MoreAdding Combined Oral Contraceptives or Metformin to Laser Treatment in Polycystic Ovarian Syndrome Hirsute Patients
March 2021 | Volume 20 | Issue 3 | Original Article | 302 | Copyright © March 2021
Background: Hirsutism is estimated to affect 10% to 20% of females, provoking significant psychological damage and social embarrassment. Polycystic ovary syndrome is a major cause of ...
Read MoreMedia and other results for: "finasteride"
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
